A study of milciclib in combination with gemcitabine in patients with refractory solid tumors.
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Gemcitabine (Primary) ; Milciclib (Primary)
- Indications Mesothelioma; Non-small cell lung cancer; Pancreatic cancer; Peritoneal cancer; Prostate cancer; Solid tumours; Thyroid cancer
- Focus Adverse reactions
- 20 Jun 2017 New trial record